Acarbose

Product NDC
68151-0537
11-digit product format
681510537
Labeler code
68151
Product ID
68151-0537_51a53a2a-d84c-4251-95d4-aca96fde8980
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acarbose
Dosage form
TABLET
Route
ORAL
Labeler
Carilion Materials Management
Application
ANDA090912
Marketing category
ANDA
Marketing start
2011-07-28
Marketing end
0000-00-00
Substance
ACARBOSE
Active strength
50 mg/1
Pharmacologic classes
alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
2712f130-8721-1a9d-6846-53893b13fb67Product name220210312

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68151-0537-12020-01-31C16284748780-19d75b9d1-1eb4-f424-e053-dadaa90a57ceAcarbose Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68151-0537-1Acarbose1 in 1 BLISTER PACKTABLET12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68151-0537ACARBOSE TABLET [CARILION MATERIALS MANAGEMENT]2Legacy NDC, 1 package rows20171228_d4741580-8b93-41e3-b85f-565cb45c7dab.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
199149acarbose 50 MG Oral TabletPSNd4741580-8b93-41e3-b85f-565cb45c7dab2
199149acarbose 50 MG Oral TabletSCDd4741580-8b93-41e3-b85f-565cb45c7dab2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
68151-0537-1681510537011 in 1 BLISTER PACKHistorical